Royal London Asset Management Ltd. Has $2.64 Million Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Royal London Asset Management Ltd. lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 282,390 shares of the pharmacy operator’s stock after selling 3,617 shares during the quarter. Royal London Asset Management Ltd.’s holdings in Walgreens Boots Alliance were worth $2,635,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. lifted its position in Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after acquiring an additional 3,329,857 shares in the last quarter. Swedbank AB boosted its holdings in shares of Walgreens Boots Alliance by 45.3% in the 4th quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock worth $5,559,000 after buying an additional 185,762 shares during the last quarter. PNC Financial Services Group Inc. grew its position in shares of Walgreens Boots Alliance by 23.4% during the 3rd quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock valued at $3,050,000 after acquiring an additional 64,586 shares during the period. Sunbelt Securities Inc. grew its holdings in Walgreens Boots Alliance by 82.8% during the third quarter. Sunbelt Securities Inc. now owns 139,377 shares of the pharmacy operator’s stock valued at $1,249,000 after purchasing an additional 63,149 shares during the period. Finally, Merit Financial Group LLC purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth about $326,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analyst Ratings Changes

WBA has been the subject of a number of analyst reports. Evercore ISI raised their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and lowered their price target for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Finally, Royal Bank of Canada increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $10.59.

Walgreens Boots Alliance Stock Up 0.5 %

WBA stock opened at $11.15 on Tuesday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The business has a 50 day moving average of $10.94 and a 200 day moving average of $9.85. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05. The firm has a market cap of $9.64 billion, a PE ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.66 EPS. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.